Microcirculation:
The microcirculation is a systemic circulation vascular channel composed of micro vessels with internal diameter of 20 m. These micro-vessels are made up of afferent arteriole, venules, capillaries, and with their cellular constituents. The microcirculation is the final destination of the cardiovascular system and is ultimately responsible for oxygen diffusion out from capillaries' red blood cells (RBC) to the parenchymal cells, where oxygen is supplied to meet the energy requirements of the tissue cells in support of their proper function and aid in having conducted activities involving tissue nourishment and perfusion.
Inflammation:
Inflammation is defined as a series of localised reactions that occur in the affected area, such as redness, swelling, stiffness, and a rise in temperature, which is the result of a local defence mechanism designed to avoid invaders or foreign pathogens from attempting to fight by circulating Neutrophils and leukocytes (WBCs), increasing blood flow, and so on. There are two types of inflammation: acute and chronic. Acute inflammation includes sore throat, swelling, illness, physical trauma, and other signs that resolve within a few hours, however persistent inflammation can lead to cancer, arthritis, asthma, Crohn's disease, and some other diseases. Certain inflammatory diseases, such as inflammatory arthritis and psoriasis, could be of hereditary origin, culminating in autoimmune inflammatory disorders. Inflammatory mediators are managed via anti-inflammatory treatment. Steroids and nonsteroidal anti-inflammatory medications may be used in anti-inflammatory drugs (Aspirin, Ibuprofen, diclofenac).
Title : The development of human relaxin-2 for heart failure with preserved ejection fraction, HFpEF
Thomas Bernd Dschietzig, Relaxera GmbH & Co. KG, Germany
Title : Surgical fetal stem cells implantation in heart failure patients long term results at 14 years
Federico Benetti, Benetti Foundation, Argentina
Title : Pulse field ablation for atrial fibrillation complications: What do we know yet
Narendra Kumar, HeartbeatsZ Academy, United Kingdom
Title : Lipoprotein (a): The hidden cardiovascular risk
Syed Raza, Awali Hospital, Bahrain
Title : Clinical pharmacology of sotatercept - The novel quality advancement in biological therapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Optimizing the role of the electrophysiology advanced practice nurse in the hospital
Esther M Weiss, Advocate Sherman Hospital, United States